Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$31,023,040
+$7,763,511 QoQ
Shares Held
40,152
+33.2% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.6674636381749353.ToString("F0")%
Shared 0.ToString("F0")%
None 99.33253636182506.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2020CallValue
$62,365
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creative Planning holds $360,280,712 across 212 Biotechnology names. REGN ranks #2 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
109,524 | $48,906,846 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
40,152 | $31,023,040 | |
| 3 | INSM |
INSMED Inc
|
72,200 | $11,806,143 | |
| 4 | EXEL |
Exelixis, Inc.
|
234,142 | $10,042,350 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
119,661 | $8,886,025 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
140,177 | $8,145,685 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,122 | $7,981,245 | |
| 8 | INCY |
Incyte Corp
|
80,874 | $7,611,860 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,023,040 | 40,152 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $23,259,529 | 30,134 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,211,100 | 19,939 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,979,625 | 9,485 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $7,209,292 | 11,367 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,235,848 | 10,158 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,397,272 | 11,793 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $10,105,650 | 9,615 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $8,300,512 | 8,624 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,226,197 | 7,089 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,487,496 | 6,668 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $4,395,308 | 6,117 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $4,738,570 | 5,767 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,695,471 | 5,122 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,024,828 | 4,391 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,319,594 | 3,924 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,885,035 | 2,699 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,720,260 | 2,724 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,485,111 | 2,454 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,669,476 | 2,989 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,983,620 | 6,306 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $2,369,654 | 4,905 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,414,890 | 4,314 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $62,365 | 100 | Call | Sole | 2020-07-23 | |
| 2020-06-30 | $2,313,117 | 3,709 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $2,022,497 | 4,142 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||